Home › Asset managers › Compare 2025-2026 › Charles Schwab vs DWS
Charles Schwab 2025-2026 · DWS 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,845 | 13,691 | 1,154 | 0 | 92.2% | 92.2% |
| Board proposals | 13,899 | 12,976 | 923 | 0 | 93.4% | 93.4% |
| E&S shareholder proposals | 155 | 108 | 47 | 0 | 69.7% | 69.7% |
| Other items | 791 | 607 | 184 | 0 | 76.7% | 76.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,154 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | DWS |
|---|---|---|---|---|---|---|
| SERVICENOW, INC. | May 21, 2026 | Shareholder proposal regarding shareholder right to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 12 funds |
FOR 20 funds |
| STEPSTONE GROUP INC | September 9, 2025 | To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law. Director Elections |
Other | For | AGAINST 4 funds |
FOR 1 fund |
| TARGET CORPORATION | June 10, 2026 | Shareholder proposal requesting policy requiring the Board Chair to be an independent director. Corporate Governance |
Other | Against | AGAINST 13 funds |
FOR 16 funds |
| TESLA, INC. | November 6, 2025 | A shareholder proposal regarding adopting targets and reporting on metrics to assess the feasibility of integrating sustainability metrics into senior executive compensation plans. Compensation |
Other | Against | AGAINST 13 funds |
FOR 12 funds |
| TESLA, INC. | November 6, 2025 | A shareholder proposal to amend the bylaws to repeal 3% derivative suit ownership threshold. Corporate Governance |
Other | Against | FOR 13 funds |
AGAINST 12 funds |
| TEXAS INSTRUMENTS INCORPORATED | April 16, 2026 | Stockholder proposal to permit stockholders to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 17 funds |
FOR 12 funds |
| THE AES CORPORATION | April 29, 2026 | If properly presented, to vote on a non-binding stockholder proposal regarding stockholder ability to call a special meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 4 funds |
| THE BOEING COMPANY | April 17, 2026 | Action by Written Consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 13 funds |
FOR 9 funds |
| THE CIGNA GROUP | April 22, 2026 | Shareholder Proposal - Shareholder Right to Act by Written Consent Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 12 funds |
| THE COCA-COLA COMPANY | April 29, 2026 | Vote on a shareowner proposal requesting a report on the Company's plans to increase sustainability disclosure Environment or Climate |
Other | Against | AGAINST 15 funds |
FOR 12 funds |
| THE GOLDMAN SACHS GROUP, INC. | April 29, 2026 | Shareholder Proposal Regarding Special Shareholder Meeting Thresholds Shareholder Rights and Defenses |
Other | Against | AGAINST 13 funds |
FOR 11 funds |
| THE HARTFORD INSURANCE GROUP, INC. | May 20, 2026 | Shareholder proposal that the Company adopt written consent rights for shareholders Shareholder Rights and Defenses |
Other | Against | AGAINST 13 funds |
FOR 11 funds |
| THE SHERWIN-WILLIAMS COMPANY | April 22, 2026 | Shareholder Proposal Regarding Shareholder Ability to Call a Special Meeting Shareholder Rights and Defenses |
Other | Against | AGAINST 13 funds |
FOR 9 funds |
| THE TIMKEN COMPANY | May 8, 2026 | Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 11 funds |
FOR 2 funds |
| THE WESTERN UNION COMPANY | May 14, 2026 | Stockholder proposal regarding stockholder right to act by written consent Shareholder Rights and Defenses |
Other | Against | AGAINST 9 funds |
FOR 1 fund |
| TRANSUNION | May 12, 2026 | Advisory vote on a stockholder proposal requesting a stockholder right to call a special meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 11 funds |
FOR 7 funds |
| TRICO BANCSHARES | May 21, 2026 | Amendment to the Company's Bylaws to eliminate cumulative voting rights. Shareholder Rights and Defenses |
Other | For | FOR 7 funds |
AGAINST 1 fund |
| ULTA BEAUTY, INC. | June 9, 2026 | To approve an amendment to our Certificate of Incorporation, as amended, to add specified forum selection provisions. Shareholder Rights and Defenses |
Other | For | AGAINST 14 funds |
FOR 10 funds |
| UNITED AIRLINES HOLDINGS, INC. | May 19, 2026 | Advisory vote on stockholder proposal entitled "Shareholder Right to Act by Written Consent". Shareholder Rights and Defenses |
Other | Against | AGAINST 13 funds |
FOR 11 funds |
| UNITED RENTALS, INC. | May 8, 2026 | Stockholder Proposal on Directors Who Fail to Obtain a Majority Vote Corporate Governance |
Other | Against | FOR 13 funds |
AGAINST 10 funds |
| VERISK ANALYTICS, INC. | May 19, 2026 | Shareholder Proposal - Shareholder Right to Act by Written Consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 17 funds |
| VERTEX PHARMACEUTICALS INCORPORATED | May 13, 2026 | Shareholder Proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 12 funds |
| VIPER ENERGY, INC. | May 19, 2026 | The approval of an amendment to the Company's certificate of incorporation to provide that stockholders holding at least 20% of the voting power, determined on a net long basis, continuously for at least one year, may call special meetings of stockholders, and other immaterial changes. Shareholder Rights and Defenses |
Other | For | AGAINST 7 funds |
FOR 1 fund |
| VISA INC. | January 27, 2026 | Shareholder proposal on shareholder right to act by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 15 funds |
FOR 18 funds |
| WEC ENERGY GROUP, INC. | May 7, 2026 | Stockholder proposal to govern by majority vote Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 7 funds |
| WELLS FARGO & COMPANY | April 28, 2026 | Shareholder Proposal - Govern by Majority Vote. Shareholder Rights and Defenses |
Other | Against | AGAINST 12 funds |
FOR 14 funds |
| WELLS FARGO & COMPANY | April 28, 2026 | Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Corporate Governance |
Other | Against | AGAINST 12 funds |
FOR 14 funds |
| WEST PHARMACEUTICAL SERVICES, INC. | May 4, 2026 | Shareholder proposal regarding an independent Board Chair policy. Corporate Governance |
Other | Against | AGAINST 13 funds |
FOR 11 funds |
| XCF GLOBAL, INC. | March 6, 2026 | To authorize an adjournment of the meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1 Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| YUM! BRANDS, INC. | May 14, 2026 | Shareholder Proposal to Reduce the Percentage of Shares Required to Call a Special Meeting. Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 10 funds |
| ZOETIS INC. | May 20, 2026 | Shareholder proposal to permit shareholder action by written consent. Shareholder Rights and Defenses |
Other | Against | AGAINST 14 funds |
FOR 15 funds |
| 1-800-FLOWERS.COM, INC. | December 10, 2025 | To approve an amendment to the 2003 Long Term Incentive and Share Award Plan to increase the authorized shares. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| 1ST SOURCE CORPORATION | April 23, 2026 | Election of Directors for terms expiring April 2029: Timothy K. Ozark Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| 1ST SOURCE CORPORATION | April 23, 2026 | Election of Directors for terms expiring April 2029: Todd F. Schurz Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| 908 DEVICES INC | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| A10 NETWORKS, INC. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Andrew Kim Director Elections |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| ACCENTURE PLC | January 28, 2026 | Appointment of the following nominees to the Board of Directors: Nancy McKinstry Director Elections |
Board | For | FOR 14 funds |
AGAINST 13 funds |
| ACLARIS THERAPEUTICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Tracy Liu Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 3 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval of an amendment to the 2022 Employee Stock Option Plan to increase the number of shares authorized for issuance as described in the Proxy Statement. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ADOBE INC. | April 15, 2026 | Approve the 2019 Equity Incentive Plan, as amended, to increase the available share reserve by 12 million shares. Compensation |
Board | For | FOR 12 funds |
AGAINST 18 funds |
| ADT Inc. | May 27, 2026 | Election of Directors To be elected for terms expiring in 2027: Danielle Tiedt Director Elections |
Board | For | FOR 13 funds |
WITHHOLD 1 fund |
| ADVANCED ENERGY INDUSTRIES, INC. | May 7, 2026 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 10 funds |
AGAINST 3 funds |
| ADVANCED FLOWER CAPITAL INC. | November 6, 2025 | To approve the application of the reduced asset coverage requirements in Section 61 (a)(2) of the 1940 Act to the Company, which would permit the Company to increase the maximum amount of leverage that it would otherwise be permitted to incur by reducing the asset coverage requirement applicable to the Company from 200% to 150%. Investment Company Matters |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ADVANCED MICRO DEVICES, INC. | May 13, 2026 | Approve an amendment and restatement of the Advanced Micro Devices, Inc. 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 16 funds |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve an amendment to the Company's 2023 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by an additional 2,500,000 shares of common stock Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| AERSALE CORPORATION | June 11, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| AERSALE CORPORATION | June 11, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Compensation |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| AGILON HEALTH, INC. | June 2, 2026 | Approval, by advisory vote, of the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 2 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Janaki Akella Director Elections |
Board | For | AGAINST 14 funds |
FOR 7 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve the Company's 2026 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 8 funds |
| ALEXANDER'S, INC. | May 21, 2026 | Approval of the Company's 2026 Omnibus Stock Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ALEXANDER'S, INC. | May 21, 2026 | Non-Binding Advisory Resolution on Executive Compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 7 funds |
| ALPHABET INC. | June 5, 2026 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock Compensation |
Board | For | FOR 16 funds |
AGAINST 25 funds |
| ALTA EQUIPMENT GROUP INC. | May 29, 2026 | To approve the First Amendment to Alta Equipment Group, Inc 2020 Omnibus Incentive Plan Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 1 fund |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| ANTERIX INC. | August 5, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Mary Dean Hall Director Elections |
Board | For | WITHHOLD 12 funds |
FOR 1 fund |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve the 2026 equity incentive plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| APPLOVIN CORPORATION | June 3, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 11 funds |
| ARBOR REALTY TRUST, INC. | May 20, 2026 | Approval of an amendment and restatement to the Arbor Realty Trust, Inc. 2024 Amended Omnibus Stock Incentive Plan (the "Plan") to authorize an additional 8,000,000 shares of common stock of Arbor Realty Trust, Inc. for issuance under the Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ARCHER AVIATION INC. | June 26, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. Audit-related |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Patrick J. Heron Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| ARS PHARMACEUTICALS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| ARTERIS, INC. | June 2, 2026 | Election of Class II directors whose current terms will expire at the annual meeting of stockholders to be held in 2026. Antonio J. Viana Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| ASPEN AEROGELS, INC. | May 13, 2026 | Approval, on a non-binding, advisory basis, of the compensation of Aspen Aerogels, Inc.'s named executive officers, as disclosed in its Proxy Statement for the 2026 Annual Meeting. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| AST SPACEMOBILE, INC. | June 12, 2026 | To approve the non-binding advisory resolution on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 2 funds |
| ATYR PHARMA, INC | May 11, 2026 | To approve an amendment to the aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended: Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AUDIOEYE, INC. | June 22, 2026 | To approve, by non-binding advisory vote, the compensation of AudioEye, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| AUTODESK, INC. | June 17, 2026 | Approve, on an advisory (non-binding) basis, the compensation of Autodesk, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 16 funds |
| AVEANNA HEALTHCARE HOLDINGS INC. | May 29, 2026 | To approve, on an advisory, non-binding, basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| AXON ENTERPRISE, INC. | May 28, 2026 | Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 11 funds |
| Abeona Therapeutics Inc. | June 12, 2026 | Election of three Class 1 Directors for a three-year term: Michael Amoroso Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| Acuren Corporation | July 31, 2025 | Election of Directors: James E. Lillie Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| Acuren Corporation | July 31, 2025 | Election of Directors: Sir Martin E. Franklin Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| Aeva Technologies, Inc. | June 18, 2026 | Election of Class II Directors: Hrach Simonian Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Aeva Technologies, Inc. | June 18, 2026 | Election of Class II Directors: Stephen Zadesky Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Air Products and Chemicals, Inc. | January 28, 2026 | Election of Directors: Tonit M. Calaway Director Elections |
Board | For | AGAINST 12 funds |
FOR 10 funds |
| Albertsons Companies, Inc. | August 7, 2025 | Election of Directors: Sharon Allen Director Elections |
Board | For | FOR 12 funds |
AGAINST 5 funds |
| Alignment Healthcare, Inc. | June 4, 2026 | Election of Directors: David Hodgson Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Alignment Healthcare, Inc. | June 4, 2026 | Election of Directors: Jacqueline Kosecoff Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Alignment Healthcare, Inc. | June 4, 2026 | Election of Directors: Jody Bilney Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Allogene Therapeutics, Inc. | June 18, 2026 | Election of Directors: Deborah Messemer Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Allogene Therapeutics, Inc. | June 18, 2026 | Election of Directors: Owen Witte, M.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Allogene Therapeutics, Inc. | June 18, 2026 | Election of Directors: Vicki Sato, Ph.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Alta Equipment Group Inc. | May 29, 2026 | Election of Directors: Colin Wilson Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| Amcor Plc | November 6, 2025 | Re-election of Directors: Lucrece Foufopoulos-De Ridder Director Elections |
Board | For | FOR 14 funds |
AGAINST 12 funds |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: Deb Autor Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: J. Kevin Buchi Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | Election of Directors: Jeff George Director Elections |
Board | For | FOR 8 funds |
AGAINST 1 fund |
← Previous Page 3 of 12 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.